{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/0185cea5-9e3b-4b82-a887-26f91f92765f/6762ec3c6ba7599e648089ef?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"The Nature Podcast festive spectacular 2024","description":"<h2>01:11 “Ozempic you’re able”</h2><p>In the first of our annual festive songs celebrating the science of the past year, we pay homage to Ozempic, or Semaglutide, that's able to tackle obesity, diabetes and potentially a whole lot more.</p><h2><br></h2><h2>05:20 A very scientific quiz</h2><p>We gather an all-star cast and see how well they can remember some of the big science stories from 2024 in our annual festive quiz.</p><p><br></p><h2>21:31 “CAR T Cells”</h2><p>In the second of our festive songs, we look at CAR-T cells. These engineered immune cells have shown great promise at tackling cancer, but these treatments are not without their drawbacks.</p><h2><br></h2><h2>25:43 Nature’s 10</h2><p>Every year, Nature’s 10 highlights some of the people who have helped shape science over the past 12 months. We hear about a few of the people who made the 2024 list, including an economist who now needs to run a country, a Russian science-sleuth, a researcher who’s been sounding the alarm on Mpox, and a PhD student who won a salary bump for researchers in Canada.</p><p><br></p><p><em>News Feature: </em><a href=\"https://www.nature.com/immersive/d41586-024-03890-5/index.html\" rel=\"noopener noreferrer\" target=\"_blank\"><em>Nature’s 10</em></a></p><p><br></p><p><a href=\"https://www.nature.com/briefing/signup\" rel=\"noopener noreferrer\" target=\"_blank\"><strong><em>Subscribe to Nature Briefing, an unmissable daily round-up of science news, opinion and analysis free in your inbox every weekday.</em></strong></a></p>","author_name":"Springer Nature Limited"}